The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of canagliflozin compared
with sitagliptin and placebo in patients with type 2 diabetes mellitus who are receiving
treatment with metformin monotherapy (i.e., treatment with a single drug) and have inadequate
glycemic (blood sugar) control.